Search Results - "ROCKSTROH, J. K."

Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans by Grimbacher, B, Salzer, U, Chapel, H M, Webster, A D B, Pan-Hammarström, Q, Schmitt-Graeff, A, Schlesier, M, Peter, H H, Rockstroh, J K, Schneider, P, Schäffer, A A, Hammarström, L

“…The functional interaction of BAFF and APRIL with TNF receptor superfamily members BAFFR, TACI and BCMA is crucial for development and maintenance of humoral…”
Get full text

European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV‐infected adults by Rockstroh, JK, Bhagani, S, Benhamou, Y, Bruno, R, Mauss, S, Peters, L, Puoti, M, Soriano, V, Tural, C

“…Objectives With the decline in HIV‐associated morbidity and mortality following the introduction of highly active antiretroviral therapy (HAART), liver disease…”
Get full text

COVID‐19 research: an opinion piece by Waters, L, Rockstroh, JK

“…The unprecedented global scale of COVID‐19 globally has triggered a race to discover interventions to reduce associated morbidity and mortality and rapid…”
Get full text

Switching tenofovir disoproxil fumarate to tenofovir alafenamide in a real life setting: what are the implications? by Schwarze‐Zander, C, Piduhn, H, Boesecke, C, Schlabe, S, Stoffel‐Wagner, B, Wasmuth, JC, Strassburg, CP, Rockstroh, JK

“…Objectives Development of novel antiretrovirals aims at reducing long‐term toxicities. Tenofovir disoproxil fumarate (TDF) has been associated with potential…”
Get full text

The Incidence of AIDS-Defining Illnesses at a Current CD4 Count ≥200 Cells/μL in the Post—Combination Antiretroviral Therapy Era by Mocroft, A., Furrer, H. J., Miro, J. M., Reiss, P., Mussini, C., Kirk, O., Abgrall, S., Ayayi, S., Bartmeyer, B., Braun, D., Castagna, A., Monforte, A. d'Arminio, Gazzard, B., Gutierrez, F., Hurtado, I., Jansen, K., Meyer, L., Muñoz, P., Obel, N., Soler-Palacin, P., Papadopoulos, A., Raffi, F., Ramos, J. T., Rockstroh, J. K., Salmon, D., Torti, C., Warszawski, J., de Wit, S., Zangerle, R., Fabre-Colin, C., Kjaer, J., Chene, G., Grarup, J., Lundgren, J. D.

“…Background. Few studies consider the incidence of individual AIDS-defining illnesses (ADIs) at higher CD4 counts, relevant on a population level for monitoring…”
Get full text

Late presentation of HIV infection: a consensus definition by Antinori, A, Coenen, T, Costagiola, D, Dedes, N, Ellefson, M, Gatell, J, Girardi, E, Johnson, M, Kirk, O, Lundgren, J, Mocroft, A, D'Arminio Monforte, A, Phillips, A, Raben, D, Rockstroh, JK, Sabin, C, Sönnerborg, A, De Wolf, F

“…Objectives Across Europe, almost a third of individuals infected with HIV do not enter health care until late in the course of their infection. Surveillance to…”
Get full text

Rates of sustained virological response 12 weeks after the scheduled end of direct‐acting antiviral (DAA)‐based hepatitis C virus (HCV) therapy from the National German HCV registry: does HIV coinfection impair the response to DAA combination therapy? by Bischoff, J, Mauss, S, Cordes, C, Lutz, T, Scholten, S, Moll, A, Jäger, H, Cornberg, M, Manns, MP, Baumgarten, A, Rockstroh, JK

“…Objectives The European Association for the Study of the Liver (EASL) treatment recommendations for hepatitis C no longer discriminate between HIV/hepatitis C…”
Get full text

Essentials from the 2015 European AIDS Clinical Society (EACS) guidelines for the treatment of adult HIV‐positive persons by Ryom, L, Boesecke, C, Gisler, V, Manzardo, C, Rockstroh, JK, Puoti, M, Furrer, H, Miro, JM, Gatell, JM, Pozniak, A, Behrens, G, Battegay, M, Lundgren, JD

“…Background The European AIDS Clinical Society (EACS) guidelines are intended for all clinicians involved in the care of HIV‐positive persons, and are available…”
Get full text

The use and impact of European Testing Week regional awareness campaigns to increase HIV and viral hepatitis testing coverage by Raben, Dorthe, Kahama, C. B., Combs, L., Stengaard, Annemarie, Rockstroh, J. K., Simões, Daniel, Collins, Ben, Zakowicz, Anna, Von Lingen, Ann‐Isabelle, Piercy, Ann, Collins, Ben, James, Cary, Simões, Daniel, Raben, Dorthe, Gordon, Igor, Lambert, John S., Belin, Janko, Farrell, Jason, Demant, Jonas, Garrido, Jorge, Begovac, Josip, James, Jules, Fernàndez‐López, Laura, Stevensson, Luca, Ankiersztejn‐Bartczak, Magdalena, Gogia, Marine, Mishkovikj, Milan, Dedes, Nikos, Panochenko, Oksana, Pasanen, Sini, Tiwana, Tajinder, Mukiwa, Takudzwa, Noori, Teymur, Moonfort, Tonni, Kovacs, Tudor, Delpech, Valerie, Dominković, Zoran, Sullivan, Ann K., Lingen, Ann‐Isabelle, Gazzard, Brian, James, Cary, Simões, Daniel, Castro, Daniela Rojas, Duffell, Erika, Bagyinszky, Ferenc, Negro, Francesco, Karpov, Igor, De Baetselier, Irith, Lambert, John S., Lazarus, Jeffrey, Lundgren, Jens, Brännström, Johanna, Casabona, Jordi, Rockstroh, Jürgen, Grazava, Kira, Cosmaro, Lella, Maistat, Liudmyla, Unemo, Magnus, Vermeulen, Mark, Matičič, Mojca, Bivol, Stela, Dedes, Nikos, Tsereteli, Nino, Patel, Rajul, Noori, Teymur, Seyler, Thomas, Platteau, Tom, Delpech, Valerie, Yazdanpanah, Yazdan

“…Introduction Since 2013, the European Testing Week (ETW) awareness campaign has become a key regional event influencing testing efforts for HIV, viral…”
Get full text

Liver stiffness regression after successful Hepatitis C treatment is independent of HIV coinfection by Malin, JJ, Boesecke, C, Schwarze‐Zander, C, Wasmuth, JC, Schlabe, S, Trebicka, J, Spengler, U, Llibre, JM, Jou, T, Vasylyev, M, Clotet, B, Rockstroh, JK

“…Objectives The aim of the study was to assess the regression of liver stiffness after successful direct‐acting antiviral (DAA) treatment in patients with…”
Get full text

Temporal changes and regional differences in treatment uptake of hepatitis C therapy in EuroSIDA by Grint, D, Peters, L, Schwarze‐Zander, C, Beniowski, M, Pradier, C, Battegay, M, Jevtovic, D, Soriano, V, Lundgren, JD, Rockstroh, JK, Kirk, O, Mocroft, A

“…Objectives All HIV/hepatitis C virus (HCV)‐coinfected patients with chronic HCV infection and ≥ F2 fibrosis should be considered for HCV therapy. This study…”
Get full text

Multiple hepatitis C virus (HCV) reinfections in HIV‐positive men who have sex with men: no influence of HCV genotype switch or interleukin‐28B genotype on spontaneous clearance by Ingiliz, P, Krznaric, I, Stellbrink, H‐J, Knecht, G, Lutz, T, Noah, C, Stocker, H, Obermeier, M, Dupke, S, Boesecke, C, Rockstroh, JK, Baumgarten, A, Hoffmann, C

“…Objectives The incidence of sexually transmitted hepatitis C virus (HCV) reinfection is on the rise in HIV‐infected men who have sex with men (MSM). Data on…”
Get full text

Pulmonary hypertension in HIV infection: a prospective echocardiographic study by Schwarze‐Zander, C, Pabst, S, Hammerstingl, C, Ohlig, J, Wasmuth, JC, Boesecke, C, Stoffel‐Wagner, B, Carstensen, A, Nickenig, G, Strassburg, CP, Rockstroh, JK, Skowasch, D, Schueler, R

“…Objectives While idiopathic pulmonary arterial hypertension (PAH) is a rare disease, it is seen more frequently in patients with HIV infection. The aim of this…”
Get full text

A call to action toward integrated testing and earlier care for viral hepatitis, HIV, STIs and TB by Raben, D, Hoekstra, M, Combs, L, Sullivan, AK, Lazarus, JV, Lambert, JS, Simões, D, Streinu‐Cercel, A, Rockstroh, JK, Streinu‐Cercel, Anca, Amato‐Gauci, Andrew, Pop, Corina Silvia, Oprea, Cristiana, Hedrich, Dagmar, Gökengin, Deniz, Schatz, Eberhard, Ghita, Eugenia, Lazarus, Jeffrey, Rockstroh, Jürgen, Tavochi, Lara, Cosmaro, Lella, Ursan, Marian, Dara, Masoud, Dascalu, Nicoleta, Dedes, Nikos, Baptista Leite, Ricardo, Pasanen, Sini, Reic, Tatjana, Platteau, Tom, Grecu, Victor, Sönnerborg, Anders, Gazzard, Brian, West, Brian, Karpov, Igor, Lundgren, Jens D., de Wit, John, Casabona, Jordi, Rockstroh, Jürgen, Cosmaro, Lella, Maistat, Liudmyla, Matičič, Mojca, Dedes, Nikos, Tsereteli, Nino, Pol, Stanislas, Platteau, Tom, Delpech, Valerie, Zuilhof, Wim, Yazdanpanah, Yazdan, Azad, Yusef, Pharris, Anastasia, Amato‐Gauci, Andrew, Noori, Teymur, Hedrich, Dagmar, Mozalevskis, Antons, Vovc, Elena, Dara, Masoud, Fenton, Kevin, Kakalou, Christine, Klavs, Irena, Wawer, Iwona, Casabona, Jordi, Hristojeva, Julia, Kivimets, Kristel, Cosmaro, Lella, Maffeo, Manuel, Kall, Meaghan, Mommi, Michele, Gasbarrini, Nadia, Wysocki, Piotr, Delpech, Valerie, Koutkias, Vassilis

“…Objectives The objective of the paper is to present the outcomes of the HepHIV 2019 conference, held in Bucharest under the Romanian EU Presidency and focusing…”
Get full text

Baseline prevalence and predictors of liver fibrosis among HIV‐positive individuals: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial by Matthews, GV, Neuhaus, J, Bhagani, S, Mehta, SH, Vlahakis, E, Doroana, M, Naggie, S, Arenas‐Pinto, A, Peters, L, Rockstroh, JK

“…Objectives Liver disease is increasingly recognized in HIV‐positive individuals, even among those without viral hepatitis, partly as a result of the recent…”
Get full text

Hepatitis C virus (HCV) RNA profiles among chronic HIV/HCV‐coinfected individuals in ESPRIT; spontaneous HCV RNA clearance observed in nine individuals by Grint, D, Tedaldi, E, Peters, L, Mocroft, A, Edlin, B, Gallien, S, Klinker, H, Boesecke, C, Kokordelis, P, Rockstroh, JK

“…Objectives Studies have shown that hepatitis C virus (HCV) RNA levels remain stable over time in HIV/HCV‐coinfected individuals taking combination…”
Get full text

Safety and efficacy of raltegravir in patients with HIV‐1 and hepatitis B and/or C virus coinfection by Rockstroh, JK, Teppler, H, Zhao, J, Sklar, P, Harvey, CM, Strohmaier, KM, Leavitt, RY, Nguyen, B‐YT

“…Objective The aim was to examine the long‐term safety and efficacy of raltegravir in patients with HIV‐1 and hepatitis B virus (HBV) and/or hepatitis C virus…”
Get full text

Lipid profiles for nevirapine vs. atazanavir/ritonavir, both combined with tenofovir disoproxil fumarate and emtricitabine over 48 weeks, in treatment‐naïve HIV‐1‐infected patients (the ARTEN study) by Podzamczer, D, Andrade‐Villanueva, J, Clotet, B, Taylor, S, Rockstroh, JK, Reiss, P, Domingo, P, Gellermann, HJ, de Rossi, L, Cairns, V, Soriano, V

“…Objectives Dyslipidaemic effects of antiretrovirals (ARVs) may contribute to increased cardiovascular risk (CR) in HIV‐1‐infected patients. The ARTEN…”
Get full text

Cancer risk in HIV-infected individuals on HAART is largely attributed to oncogenic infections and state of immunocompetence by Vogel, M, Friedrich, O, Lüchters, G, Holleczek, B, Wasmuth, J C, Anadol, E, Schwarze-Zander, C, Nattermann, J, Oldenburg, J, Sauerbruch, T, Rockstroh, J K, Spengler, Ulrich

“…To estimate the cancer risk of HIV-infected patients in the HAART era with respect to a general reference population and to determine risk factors for…”
Get full text

The HepHIV 2017 Conference in Malta: joining forces for the earlier diagnosis of HIV and viral hepatitis by Raben, D, Hoekstra, M, Sperle, I, Amato Gauci, AJ, Gauci, C, West, B, Sullivan, A, Lazarus, JV, Platteau, T, Rockstroh, JK, Lingen, Ann‐Isabelle, Schatz, Eberhard, Godfrey, Fiona, Galea, George, Lundgren, Jens D, Wit, John, Maistat, Ludmila, Donoghoe, Martin, Kaye, Per, Damme, Pierre, Mauss, Stefan, Reic, Tatjana, Zuilhof, Wim, Casabona, ordi, Dedes, Nikos, Delpech, alerie, Gatell, osé, Gazzard, Brian, Matičič, Mojca, Pol, Stanislas, Sönnerborg, Anders, Tsereteli, Nino

“…Objectives The objective of the article is to provide an overview of the results of the HepHIV 2017 Conference organized by the HIV in Europe initiative under…”
Get full text